Literature DB >> 3094714

Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction.

G A Oswald, C C Smith, D J Betteridge, J S Yudkin.   

Abstract

Determinants of plasma glucose concentrations were studied in patients on admission to hospital with confirmed acute myocardial infarction but without previous glucose intolerance as evidenced by raised concentrations of glycosylated haemoglobin (HbAlc). Mortality in hospital increased significantly with increasing plasma concentrations of glucose in patients with both normal (p less than 0.0001, n = 311) and borderline (p less than 0.02, n = 70) concentrations of HbAlc. There was a weak relation between plasma glucose concentrations and infarct size as estimated by peak aspartate transaminase activity in both HbAlc groups (rs = 0.26, n = 101 and rs = 0.41, n = 35 respectively). A correlation was found between adrenaline and plasma glucose concentrations (r = 0.47, n = 27) and cortisol and plasma glucose concentrations (r = 0.75, n = 19), but the relation of plasma noradrenaline and plasma glucose suggested a threshold effect. Concentrations of adrenaline, but not those of noradrenaline or cortisol, correlated with infarct size as measured both by peak aspartate transaminase activity and cumulative release of creatine kinase MB isoenzyme. Multiple regression analysis showed that concentrations of cortisol, adrenaline, and noradrenaline (but not the concentration of HbAlc, infarct size, or age) are the main determinants of plasma glucose concentration measured in non-diabetic patients when admitted to hospital after acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094714      PMCID: PMC1341710          DOI: 10.1136/bmj.293.6552.917

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  24 in total

1.  Nasal mucociliary clearance in man.

Authors:  D F Proctor; G K Adams; I Andersen; S F Man
Journal:  Ciba Found Symp       Date:  1978

2.  Plasma norepinephrine in congestive heart failure.

Authors:  J A Thomas; B H Marks
Journal:  Am J Cardiol       Date:  1978-02       Impact factor: 2.778

3.  Norepinephrine: hormone and neurotransmitter in man.

Authors:  A B Silverberg; S D Shah; M W Haymond; P E Cryer
Journal:  Am J Physiol       Date:  1978-03

4.  Serum glucagon and insulin levels and their relationship to blood glucose values in patients with acute myocardial infarction and acute coronary insufficiency.

Authors:  J T Willerson; D R Hutcheson; S J Leshin; G R Faloona; R H Unger
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

5.  Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction.

Authors:  N J Christensen; J Videbaek
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

6.  Adrenocortical, insulin and metabolic changes in response to acute myocardial infarction.

Authors:  P Burckhardt; J P Felber; C Perret
Journal:  Helv Med Acta       Date:  1972

7.  Serial determination of plasma catecholamines in myocardial infarction.

Authors:  J Videbaek; N J Christensen; B Sterndorff
Journal:  Circulation       Date:  1972-11       Impact factor: 29.690

8.  The reflex stimulation of catecholamine secretion during the acute stage of myocardial infarction in the dog.

Authors:  J Staszewska-Barczak
Journal:  Clin Sci       Date:  1971-11       Impact factor: 6.124

9.  Enzymatic indices of myocardial necrosis: influence on short- and long-term prognosis after myocardial infarction.

Authors:  P L Thompson; E E Fletcher; V Katavatis
Journal:  Circulation       Date:  1979-01       Impact factor: 29.690

Review 10.  The effect of diabetes on blood flow properties.

Authors:  D E McMillan
Journal:  Diabetes       Date:  1983-05       Impact factor: 9.461

View more
  51 in total

1.  A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes.

Authors:  K Foo; J Cooper; A Deaner; C Knight; A Suliman; K Ranjadayalan; A D Timmis
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

2.  Prevalence of stress hyperglycemia among hepatopancreatobiliary postoperative patients.

Authors:  Zeya Shi; Siyuan Tang; Yuxiang Chen; Jinxu Yang; Bo Jiang; Xiaoming Liu; Xu Zhou; Xiaoji Pan; Juan Yang; Jinshu Wu; Hongjuan Hu; Binbin Ji; Xiaolin Lin; Sanmei Chen; Juan Zhang
Journal:  Int J Clin Exp Med       Date:  2013-09-25

3.  Insulin infusion in diabetic patients with acute myocardial infarction.

Authors:  G Davey; P Mckeigue
Journal:  BMJ       Date:  1996-09-14

Review 4.  An overview of glycemic control in the coronary care unit with recommendations for clinical management.

Authors:  Mikhail Kosiborod; Prakash Deedwania
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

5.  Stress hyperglycemia and cause of death in non-diabetic patients with myocardial infarction.

Authors:  J S Yudkin; G A Oswald
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-21

Review 6.  Hyperglycemia in nondiabetic patients presenting with acute myocardial infarction.

Authors:  Binita Shah; Nicholas S Amoroso; Steven P Sedlis
Journal:  Am J Med Sci       Date:  2012-04       Impact factor: 2.378

7.  Transient hyperglycemia in acute childhood illnesses: to attend or ignore?

Authors:  P Gupta; G Natarajan; K N Agarwal
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

8.  Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction.

Authors:  G A Oswald; C C Smith; A P Delamothe; D J Betteridge; J S Yudkin
Journal:  Br Heart J       Date:  1988-06

9.  Cardiac contractile dysfunction during acute hyperglycemia due to impairment of SERCA by polyol pathway-mediated oxidative stress.

Authors:  Wai Ho Tang; Wing Tim Cheng; Gennadi M Kravtsov; Xiao Yong Tong; Xiu Yun Hou; Sookja K Chung; Stephen Sum Man Chung
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-23       Impact factor: 4.249

10.  Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission.

Authors:  J Sala; R Masiá; F-J González de Molina; J M Fernández-Real; M Gil; D Bosch; W Ricart; M Sentí; J Marrugat
Journal:  J Epidemiol Community Health       Date:  2002-09       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.